DE69130544T2 - Bakterielle Vektoren - Google Patents

Bakterielle Vektoren

Info

Publication number
DE69130544T2
DE69130544T2 DE69130544T DE69130544T DE69130544T2 DE 69130544 T2 DE69130544 T2 DE 69130544T2 DE 69130544 T DE69130544 T DE 69130544T DE 69130544 T DE69130544 T DE 69130544T DE 69130544 T2 DE69130544 T2 DE 69130544T2
Authority
DE
Germany
Prior art keywords
lactis
plasmid
dna
hybrid vector
gene
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69130544T
Other languages
German (de)
English (en)
Other versions
DE69130544D1 (de
Inventor
Albert Dr. Ch-4056 Basle Schmitz
Bruno Dr. Ch-4051 Basle Suri
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Societe des Produits Nestle SA
Nestle SA
Original Assignee
Societe des Produits Nestle SA
Nestle SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Societe des Produits Nestle SA, Nestle SA filed Critical Societe des Produits Nestle SA
Publication of DE69130544D1 publication Critical patent/DE69130544D1/de
Application granted granted Critical
Publication of DE69130544T2 publication Critical patent/DE69130544T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/70—Vectors or expression systems specially adapted for E. coli
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/74—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
    • C12N15/746—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora for lactic acid bacteria (Streptococcus; Lactococcus; Lactobacillus; Pediococcus; Enterococcus; Leuconostoc; Propionibacterium; Bifidobacterium; Sporolactobacillus)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/315—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81—Protease inhibitors
    • C07K14/815—Protease inhibitors from leeches, e.g. hirudin, eglin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/74—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
    • C12N15/75—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora for Bacillus
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/822—Microorganisms using bacteria or actinomycetales
    • Y10S435/853—Lactobacillus

Landscapes

  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicinal Chemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Peptides Or Proteins (AREA)
DE69130544T 1990-03-22 1991-03-13 Bakterielle Vektoren Expired - Fee Related DE69130544T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB909006400A GB9006400D0 (en) 1990-03-22 1990-03-22 Bacterial vectors

Publications (2)

Publication Number Publication Date
DE69130544D1 DE69130544D1 (de) 1999-01-14
DE69130544T2 true DE69130544T2 (de) 1999-04-29

Family

ID=10673033

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69130544T Expired - Fee Related DE69130544T2 (de) 1990-03-22 1991-03-13 Bakterielle Vektoren

Country Status (22)

Country Link
US (1) US5559007A (enExample)
EP (1) EP0449770B1 (enExample)
JP (1) JPH04211384A (enExample)
KR (1) KR910016930A (enExample)
AR (1) AR245504A1 (enExample)
AT (1) ATE174055T1 (enExample)
AU (1) AU643511B2 (enExample)
BR (1) BR9101137A (enExample)
CA (1) CA2038706A1 (enExample)
DE (1) DE69130544T2 (enExample)
DK (1) DK0449770T3 (enExample)
ES (1) ES2125864T3 (enExample)
FI (1) FI911367L (enExample)
GB (1) GB9006400D0 (enExample)
HU (1) HUT57263A (enExample)
IE (1) IE910948A1 (enExample)
MX (1) MX25027A (enExample)
NO (1) NO911138L (enExample)
NZ (1) NZ237506A (enExample)
PT (1) PT97081B (enExample)
TW (1) TW213488B (enExample)
ZA (1) ZA912114B (enExample)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5286361A (en) * 1992-10-19 1994-02-15 Regents Of The University Of California Magnetically attached sputter targets
WO1996032486A1 (en) * 1995-04-11 1996-10-17 Nederlandse Organisatie Voor Toegepast-Natuurwetenschappelijk Onderzoek Tno Method for the construction of vectors for lactic acid bacteria like lactobacillus such that the bacteria can efficiently express, secrete and display proteins at the surface
GB9521568D0 (en) * 1995-10-20 1995-12-20 Lynxvale Ltd Delivery of biologically active polypeptides
EP0925364B1 (en) * 1996-09-06 2002-10-23 Bioteknologisk Institut A lactic acid bacterial regulatable expression system
EP1239032A1 (en) * 2001-03-02 2002-09-11 Société des Produits Nestlé S.A. Lactic acid bacteria as agents for treating and preventing allergy
US7780961B2 (en) 2001-05-03 2010-08-24 Actogenix N.V. Self-containing Lactococcus strain
EP1513545B1 (en) 2002-06-19 2008-03-19 Actogenix N.V. Methods and means to promote gut absorption
WO2004046346A2 (en) * 2002-11-15 2004-06-03 Vib Vzw Self-containing lactobacillus strain
ES2405552T3 (es) 2005-11-29 2013-05-31 Actogenix N.V. Inducción de tolerancia mucosa a antiantígenos de células beta de islotes pancreáticos
EP3124614B1 (en) 2007-01-12 2022-06-08 Intrexon Actobiotics NV Lactococcus promoters and uses thereof
EP2774621B1 (en) 2007-01-25 2018-01-24 Intrexon Actobiotics NV Treatment of immune disease by mucosal delivery of antigens
JP5126879B2 (ja) * 2007-07-13 2013-01-23 独立行政法人海洋研究開発機構 新規ｄｎａ断片およびそれを含む組換えベクター、それらによって形質転換された形質転換体、ならびにそれらの利用
EP2344626B1 (en) 2008-09-29 2017-03-29 Intrexon Actobiotics NV Reduced colonization of microbes at the mucosa
WO2010124855A1 (en) 2009-04-30 2010-11-04 Actogenix Nv Cryoprotectants for freeze drying of lactic acid bacteria
EP2275527A1 (en) 2009-07-17 2011-01-19 ActoGeniX NV Animal component-free culture medium for bacterial fermentation
EP3192873A1 (en) 2009-09-29 2017-07-19 Intrexon Actobiotics NV Lactobacillus and streptococcus promoters and uses thereof
AU2011268146A1 (en) 2010-06-17 2013-01-10 Actogenix Nv Compositions and methods for treating inflammatory conditions
US9920324B2 (en) 2011-06-01 2018-03-20 Intrexon Actobiotics Nv Polycistronic expression system for bacteria
EP2758512B1 (en) 2011-09-23 2018-05-09 Intrexon Actobiotics NV Modified gram positive bacteria and uses thereof
BR112014006883A8 (pt) 2011-09-23 2018-06-26 Actogenix Nv bactéria gram-positiva não patogênica carecendo de atividade do componente llc do sistema pts celobiose específico (ptcc), medicamento, aditivo alimentar, composição probiótica, ou cultura iniciadora, produto alimentar e métodos
EP3402499B1 (en) 2016-01-14 2021-07-21 Intrexon Actobiotics NV Compositions and methods for the treatment of type 1 diabetes
EP3601572A4 (en) * 2017-03-22 2021-01-06 Agency for Science, Technology and Research PROTEIN EXPRESSION CONSTRUCTION AND RELATED PROCESSES
CN116144690A (zh) * 2022-08-23 2023-05-23 江西省科学院微生物研究所(江西省流域生态研究所) 一种大肠杆菌与乳酸菌的穿梭载体pDXA及构建方法与应用
WO2025233675A1 (en) 2024-05-10 2025-11-13 Institut Pasteur Use of talosaminidase to regulate populations of archaeal methanogens in industrial, agricultural and medical settings

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL8400687A (nl) 1984-03-02 1985-10-01 Unilever Nv Recombinant plasmiden; recombinant plasmiden bevattende bacterien; werkwijze voor het bereiden of vervaardigen van een zuivelproduct; werkwijze voor het bereiden van een eiwit.
ATE64956T1 (de) 1984-06-14 1991-07-15 Ciba Geigy Ag Verfahren zur herstellung von thrombininhibitoren.
NL8503316A (nl) * 1985-11-29 1987-06-16 Stichting Nl I Zuivelonderzoek Werkwijze voor het bereiden van proteinen met behulp van gastheer-organismen, in het bijzonder melkzuurbacterien, welke recombinant dna-plasmiden met een hoge replicon-aktiviteit en een hoge promotor-aktiviteit voor het betreffende proteine-coderende gen bevatten, de van dergelijke recombinant dna-plasmiden voorziene gastheerorganismen, de recombinant dna-plasmiden zelve, de replicon-aktiviteit en promotor-aktiviteit coderende dna-fragmenten, alsmede de verkregen proteinen.
EP0316677A3 (en) 1987-11-13 1990-04-25 Miles Inc. Method for cloning in lactic acid bacteria
NL9000753A (nl) * 1990-03-30 1991-10-16 Nl Zuivelonderzoek Inst Dna-fragment, ten minste coderend voor een deel van het extracellulaire eiwit met een schijnbaar molecuulgewicht van 60 kda van lactococcus lactis stammen zoals de lactococcus lactis ssp. lactis stam mg1363, combinaties hiervan met voor homologe of heterologe eiwitten coderende dna-sequenties alsmede de hiermee verkregen homologe en heterologe eiwitten.

Also Published As

Publication number Publication date
NZ237506A (en) 1992-12-23
ZA912114B (en) 1992-01-29
MX25027A (es) 1993-12-01
EP0449770A2 (en) 1991-10-02
FI911367A7 (fi) 1991-09-23
PT97081A (pt) 1991-11-29
PT97081B (pt) 1998-07-31
NO911138D0 (no) 1991-03-21
BR9101137A (pt) 1991-11-05
FI911367A0 (fi) 1991-03-20
CA2038706A1 (en) 1991-09-23
GB9006400D0 (en) 1990-05-23
HUT57263A (en) 1991-11-28
JPH04211384A (ja) 1992-08-03
ATE174055T1 (de) 1998-12-15
DE69130544D1 (de) 1999-01-14
TW213488B (enExample) 1993-09-21
HU910958D0 (en) 1991-10-28
IE910948A1 (en) 1991-09-25
AU643511B2 (en) 1993-11-18
KR910016930A (ko) 1991-11-05
FI911367L (fi) 1991-09-23
US5559007A (en) 1996-09-24
ES2125864T3 (es) 1999-03-16
NO911138L (no) 1991-09-23
DK0449770T3 (da) 1999-06-23
EP0449770B1 (en) 1998-12-02
EP0449770A3 (en) 1992-07-01
AU7355891A (en) 1991-10-03
AR245504A1 (es) 1994-01-31

Similar Documents

Publication Publication Date Title
DE69130544T2 (de) Bakterielle Vektoren
DE3177298T2 (de) Verbesserte vektoren, verfahren zur herstellung solcher vektoren und zur expression von klonierten genen.
EP0099084B1 (de) Verfahren zur Herstellung von Interferon und Expressionsvektoren dafür
DE68929115T2 (de) Verfahren zur Herstellung von menschlichem Serumalbumin in Hefe
DE68926882T2 (de) Plasmidvektor mit pectatlyase-signalsequenz
DE3050725C2 (enExample)
DE69228705T2 (de) Methode zur rückfaltung von igf-i in eine aktive konformation
DE3020528C2 (enExample)
DE3687266T2 (de) Bakterielle enzyme und verfahren fuer deren produktion.
DD159782A5 (de) Verfahren zur herstellung eines eine immunologische oder biologische aktivitaet von humanleukozyten-interferon aufweisendes polypeptids
DD212532A5 (de) Verfahren zur stabilisierung und selektion von wirtszellen, die rekombinierende dna enthalten
DD209476A5 (de) Verfahren zur stabilisierung und selektierung von wirtszellen, die rekombinierende dna enthalten
DE69415085T2 (de) Promotor DNA Fragment von coryneformen Bakterien
DE3390105T1 (de) Rekombinantes DNA-Molekul, transformierter Mikroorganismus und Verfahren zur Herstellung von Protein A
DE3382607T2 (de) Plasmide mit konditionalem unkontrolliertem replikationsverhalten.
DE3332264A1 (de) Plasmidvektoren zur expression in bacillus subtilis und verfahren zu ihrer herstellung
WO1988000238A1 (fr) Procede pour la production genetique de proteines en utilisant des cellules hotes gram-negatives
DE3751564T2 (de) Verfahren zur Stabilisierung eines Plasmids, das in einem Bakterienstamm enthalten ist und der erhaltene Stamm.
Heffron et al. Tn3 encodes a site-specific recombination system: identification of essential sequences, genes, and the actual site of recombination
DE3687112T2 (de) Verfahren zur ausscheidung von genprodukten in das wachstumsmedium von gram-negativen bakterien.
DE3880520T2 (de) Rekombinantes plasmid fuer die expression von l-phenylalanin-ammonialyase und transformierte staemme, die es enthalten.
DE3226515A1 (de) Expressionsvektoren
EP0244627A2 (de) Expressionsvektoren zur Gewinnung von Polypeptiden
DE69429315T2 (de) Nukleinsäuresequenzen und Plasmide, die mindestens einen Resistenzmechanismus gegen Phagen aufweisen, sie enthaltende Bakterien und ihre Verwendung
DE69104357T2 (de) Klonierungs- und/oder expressionsvektoren, verfahren zur ihrer herstellung und verwendung.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee